Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Cellular & Gene Therapy Products

Cellular & Gene Therapy Products

                        Approved Cellular and Gene Therapy Products Home
          Vaccines, Blood & Biologics
          Cellular & Gene Therapy Products
          Resources Related to Regenerative Medicine TherapiesCellular & Gene Therapy Products Resources Related to Regenerative Medicine Therapies
  
  	
    Share
    Post
    Linkedin

    Email
    PrintRegenerative medicine therapies (RMTs) are defined in section 506(g)(8) of the Food Drug & Cosmetic Act as including cell therapies, therapeutic tissue engineering products, human cell and tissue products, and combination products using any such therapies or products, except for those regulated solely under section 361 of the Public Health Service Act (42 U.S.C. 264) and Title 21 of the Code of Federal Regulations Part 1271 (21 CFR Part 1271).

Based on FDA’s interpretation of section 506(g), human gene therapy products, including genetically modified cells that lead to a sustained effect on cells or tissues, and xenogeneic cell products may meet the definition of an RMT. Further, for the purposes of section 506(g)(8), FDA interprets cell therapies to include both allogeneic and autologous cell therapies. Microorganisms (e.g., viruses, bacteria, fungi) that are not genetically modified do not meet the definition of regenerative medicine therapy.

Section 3033 of the 21st Century Cures Act established the Regenerative Medicine Advanced Therapy Designation (RMAT) to facilitate the development and review of certain RMTs. Additional information on RMTs and the RMAT designation can be found at the websites listed below.

**Information on FDA’s Framework for the Regulation of Regenerative Medicine Products**

https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/framework-regulation-regenerative-medicine-products
	https://www.fda.gov/news-events/press-announcements/fda-announces-comprehensive-regenerative-medicine-policy-framework
	https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-fdas-comprehensive-new-policy-approach-facilitating**Overview of FDA’s Regenerative Medicine Advanced Therapy Designation**

https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/regenerative-medicine-advanced-therapy-designation**Cellular & Gene Therapy Guidances**

**Guidances related to the development of regenerative medicine therapies**

https://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/default.htm**CBER Standards Development Activities Related to Regenerative Medicine**

https://www.fda.gov/vaccines-blood-biologics/standards-development-regenerative-medicine-therapies**CBER Workshops, Meetings, & Conferences**

https://www.fda.gov/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/default.htmTissue & Advanced Therapies Research

**CBER Research Related to Regenerative Medicine**

https://www.fda.gov/vaccines-blood-biologics/biologics-research-projects/tissue-advanced-therapies-research**CBER Regenerative Medicine Fellowship**

https://www.fda.gov/vaccines-blood-biologics/regenerative-medicine-fellowship-under-service-fellowship-program-cber**Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA’s new policy steps and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine**

https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-fdas-new-policy-steps-and-enforcement-efforts-ensure**Webcast recording: Are Stem Cells Ready for Prime Time? A Look at FDA Research Advances in Regenerative Medicine**

https://www.fda.gov/science-research/about-science-research-fda/are-stem-cells-ready-prime-time-look-fda-research-advances-regenerative-medicine**Consumer Update: FDA Warns About Stem Cell Therapies**

https://www.fda.gov/consumers/consumer-updates/fda-warns-about-stem-cell-therapies**Remarks by Commissioner Gottlieb to the Alliance for Regenerative Medicine's Annual Board Meeting**

https://www.fda.gov/news-events/speeches-fda-officials/remarks-alliance-regenerative-medicines-annual-board-meeting-05222018**CBER Regenerative Medicine Advanced Therapy Designation Requests**

https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/cumulative-cber-regenerative-medicine-advanced-therapy-rmat-designation-requests-received-fiscal

                                                                                  Content current as of:
      10/19/2020
              
              
Regulated Product(s)
		 BiologicsCellular & Gene Therapy Products

          
                        Approved Cellular and Gene Therapy Products
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop